Melanoma Matters Pod
Melanoma Matters
From the UK to the USA - Melanoma Matters is on a mission! Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s). #MelanomaMatters video podcast
Be sure to visit the podcast's website and support the creator: www.melanomamatters.com
Author
Melanoma Matters Pod
Category
Podcast website
Latest episode
Oct 16, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Ep 45: KEYNOTE 006 10 year follow-up 14.10.2024 39:45
Summary Left siding, Starfishing, and Superstitions! We make a hidden shoutout to Owen and a subtle callout to Zayd ... if you're listening In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin delve into the Keynote 006 study, exploring its implications for melanoma treatment, long-term follow-up, and patient outcomes. The conversation highlights the importance of understand...
Ep 44: Treatment Beyond Progression 14.10.2024 28:56
Summary More stories about medical emergencies! In this conversation, James Larkin and Sapna Patel discuss the complexities of tumor dynamics in patients treated with pembrolizumab beyond disease progression. They share personal anecdotes about medical emergencies on flights, which lead into a deeper exploration of treatment strategies and clinical trial methodologies. The discussion emphasizes th...
Ep 43: Mucosal Melanoma 14.10.2024 29:17
Summary In this episode of Melanoma Matters, Sapna and James discuss the importance of looking at Figure 1. They talk about in-flight medical emergencies, and James recalls a scene of carnage ... "blood everywhere." They delve into the complexities of mucosal melanoma, discussing its unique characteristics, treatment options, and the latest research findings. They share personal anecdotes from the...
Ep 42: RELATIVITY 020 14.10.2024 31:50
Summary James' favorite moments from #ESMO24 include footie and a not-so-chance encounter with NEJM Editor-in-Chief, Eric Rubin. In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin discuss the Relativity 020 study, which focuses on Nivo Rela after PD-1 exposure in melanoma patients. They reflect on their experiences at ESMO, including networking and memorable moments, before di...
Ep 41: Ipi 10 mg/kg v 3 mg/kg 14.10.2024 26:40
Summary In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel reflect on their experiences at ESMO 2024 and the importance of face-to-face meetings. But then James pops the balloon by commenting on the carbon footprint of the airplane travel. They go on to discuss the phase three trial comparing ipilimumab doses in melanoma and delve into the trial's design, results, and implicat...
Ep 40: CheckMate 238 Post-Recurrence Outcomes 14.10.2024 33:06
Summary In this episode, James needs some sun cream! The conversation discusses the outcomes of post-recurrence systemic therapy following adjuvant checkpoint inhibitor treatment for resected melanoma in the Checkmate 238 trial. The study found that early recurrences were associated with worse outcomes compared to late recurrences. Patients who recurred early had shorter progression-free survival...
Ep 39: LEAP 004 & 003 14.10.2024 28:19
Summary (Coach) Owen is in a seriously bad mood with James at the moment! But James is back in pull-up form and can do an impressive number of strict pull-ups... In this episode, Sapna Patel and James Larkin discuss the LEAP 004 and LEAP 003 studies, focusing on the combination of lenvatinib and pembrolizumab in treating melanoma, particularly in patients who are refractory to PD-1 inhibitors. The...
Ep 38: TIL v. Ipi 14.10.2024 34:25
Summary On the heels of the great ESMO 2024 session with Toni Ribas, Inge Marie Svane, and Olivier Michielin James and Sapna discuss Prof Svane and Prof van Haanen's TIL trial, a significant study in melanoma treatment that explores the efficacy and safety of tumor-infiltrating lymphocyte (TIL) therapy compared to traditional treatments. They delve into the historical context of the trial, its...
Ep 37: CheckMate 511 14.10.2024 31:10
Summary In this episode of Melanoma Matters, host James Larkin uses his 1-800-Operator voice until co-host Sapna Patel reminds him to use his podium voice. There is a noisy wardrobe choice (SP) and a fact check of a fact check (JL). Sapna and James have an in-depth conversation of the Checkmate 511 study, discussing its implications for treatment regimens in melanoma. They delve into the nuances o...
Ep 36: Indirect comparison CM 067 v RELA 047 14.10.2024 24:31
Summary James is back from holiday and tells us the peak, pit, and bud of his time away. (Spoiler: the pit was NOT a broken tooth!) He also shares a tip for time management and email hygiene on holiday. Sapna makes an unfortunate wardrobe choice (noisy, not visual). In this episode of Melanoma Matters, hosts Sapna and James delve into the complexities of indirect treatment comparisons in melanoma...
Ep 35: End of Life care 14.10.2024 40:28
Summary Our hosts guilty pleasures - junk food and South Park! Endless laughs about South Park... In this episode of Melanoma Matters, Sapna Patel and James Larkin discuss the complexities of end-of-life care in patients with melanoma. They explore the importance of early conversations about treatment options, the role of palliative care, and the emotional and cultural aspects of dying. The discus...
Ep 34: CHOPIN & SCANDIUM trials for Uveal Melanoma 14.10.2024 10:22
Summary In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel discuss a couple of liver-directed trials in metastatic uveal melanoma. They focus on the CHOPIN and SCANDIUM trials, the combination of liver-directed therapies with systemic treatments, and the safety and efficacy of these approaches. The conversation highlights the innovative efforts of European investigators and th...
Ep 33: Percutaneous Hepatic Infusion for Uveal Melanoma 14.10.2024 41:07
Summary Warning: we recorded ANOTHER 40-minute episode on uveal melanoma! But this time we decided *not* to split it into 2 episodes. So dig in for a long one...there's the use of props at the end! In this conversation, James and Sapna discuss the FOCUS trial and the use of the melphalan hepatic delivery system. The discussion highlights the importance of understanding the differences between infu...
Ep 32: Ipi Nivo for Uveal Melanoma 14.10.2024 29:02
Summary Find out which host is a french fry aficianado, who loves a doner kebab as a guilty pleasure, and other cheeky indulgences (Lebowski's, Gettysburger, Union Rings, Freedom Fries, Law & Order: SVU...) In this conversation, hosts Sapna Patel and James Larkin discuss the latest findings and studies related to uveal melanoma treatments, particularly focusing on the combination of nivolumab...
Ep 31: Tebentafusp for Uveal Melanoma (Part Two) 14.10.2024 23:31
Summary Hosts James Larkin and Sapna Patel have a bit of fun around the words juice, wimpy, lobster red, and 3 inches. The conversation about tebentafusp in uveal melanoma continues, focusing on the concept of treating beyond progression, the tolerability of treatments, survival outcomes, and the implications of HLA frequency in patient selection for clinical trials. The speakers discuss the impor...
Ep 30: Tebentafusp for Uveal Melanoma (Part One) 14.10.2024 22:27
Summary Step aerobics, DOMS, and Princess Diana all in one opening story. In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel discuss the drug tebentafusp and its implications in treating uveal melanoma. They explore the study design, patient demographics, and the significance of overall survival rates in clinical trials. The discussion highlights the innovative nature of teben...
Ep 29: COMBI-AD long-term follow-up (10y) 14.10.2024 33:46
Summary James recalls a concert in Juan-les-Pins in Antibes, France where he saw one of the best performances he can remember (swanky locale under the pines). And a tip of the hat to the Wedding Present whose gigs he says were "always amazing" In this episode of Melanoma Matters, James and Sapna discuss the long-term follow-up results of the COMBI-AD study, which evaluates the efficacy of adjuvant...
Ep 28: RELATIVITY 048 14.10.2024 33:07
Summary Hosts Sapna Patel and James Larkin discuss what they're currently watching on tv & streaming services. (Spoiler: Eric Cartman on Ozempic) The main conversation delves into the Relativity 48 study of triple immune checkpoint inhibition presented at ASCO 2024. The hosts discuss the study's design, patient characteristics, safety profile, and efficacy results, highlighting the importance...
Ep 27: NADINA in practice 14.10.2024 38:19
Summary How many countries are there in the world? 195 according to the United Nations. (Host James Larkin nearly got it right) In this episode of Melanoma Matters, Sapna and James discuss recent developments in melanoma treatment, focusing on the FDA's recent ODAC vote regarding neoadjuvant trial designs and the implications of the Nadina data. They explore the importance of pathology in treatmen...
Ep 26: NADINA w Christian Blank 14.10.2024 28:06
Summary In this episode, Prof Christian Blank introduces us to a woman named NADINA. We find out what kind of car he drives as well as James when he's not cycling around London (hint: adoks backwards). We fixed the sound and video at the end, so you can have a laugh along with us. Christian discusses with James and Sapna the NADINA trial, combination neoadjuvant therapy for melanoma. He emphasizes...
Ep 25: Best of ASCO 2024 with Jeff Weber 14.10.2024 18:46
We dedicate this episode to our friend and colleague, Prof Jeff Weber (1952 - 2024). In this conversation, Jeff discusses the best of ASCO 2024 for melanoma and skin cancers. He presents the findings of the V940 trial, which showed a benefit in recurrence-free survival and distant metastasis-free survival for a personalized mRNA neoantigen vaccine combined with pembrolizumab. He also discusses the...
Ep 24: SECOMBIT 14.10.2024 28:49
Summary James is ill (apparent in his voice)! Find out what gets James to show up to an ASCO meeting, and stay tuned for the fact check to hear the infamous tweet from Omid Hamid regarding James' scrubs. In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel discuss sequencing of immunotherapy and targeted therapy for BRAF-positive melanoma. They review the SECOMBIT study 4-year u...
Ep 23: DREAMSeq 14.10.2024 32:38
Summary In this conversation, Sapna puts Santa Fe, NM on the map of her all time favorite places in the USA. James and Sapna go on to discuss the DreamSeq study, which focuses on the sequencing of systemic therapy in patients with BRAF mutant metastatic melanoma. They explore the historical context of melanoma treatments, the design and endpoints of the trial, and the implications for clinical pra...
Ep 22: Triplets for BRAF+ melanoma 14.10.2024 36:22
Summary James is ageist in his music preferences! Or he's just very fond of Bob Dylan. He claims to have no knowledge of Taylor Swift poetry, which is just begging for a TTPD vinyl EP. Sapna and James go on to discuss the implications of triplet studies in melanoma treatment, focusing on the combination of BRAF and MEK inhibitors with checkpoint inhibitors. They explore the results of key studies...
Ep 21: Lifileucel 14.10.2024 24:23
Summary Snoozing versus getting up before the alarm - guess which host is which. In this conversation, Sapna Patel and James Larkin discuss the recent approval of Lifileucel, a cellular therapy for melanoma. They delve into the study schema, the differences between cryopreserved and non-cryopreserved cells, and the mechanism of action involving T cells and interleukin-2. The discussion also covers...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.